ARTICLE | Clinical News

CCP-08 regulatory update

December 30, 2016 10:00 PM UTC

Vernalis and Tris said FDA accepted for review an NDA for CCP-08, an undisclosed, extended-release cough and cold product. The PDUFA date is Aug. 4. The NDA acceptance triggered an undisclosed milesto...

BCIQ Company Profiles

Tris Pharma Inc.

Vernalis plc